US Stock MarketDetailed Quotes

MLTX MoonLake Immunotherapeutics

Watchlist
  • 41.970
  • -0.660-1.55%
Close May 9 16:00 ET
  • 41.970
  • 0.0000.00%
Post 16:01 ET
2.64BMarket Cap-58291P/E (TTM)

MoonLake Immunotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-65.64%-14.95M
23.47%-42.78M
-6.45%-12.34M
1.08%-9.25M
41.43%-12.16M
36.38%-9.02M
-55.89M
-11.6M
-363.27%-9.35M
-20.76M
Net income from continuing operations
-14.38%-13.98M
31.67%-44.08M
52.10%-7.89M
21.18%-11.62M
29.07%-12.35M
23.05%-12.22M
---64.51M
---16.47M
-134.44%-14.74M
---17.42M
Operating gains losses
97.95%-272
-128.04%-85.25K
-145.21%-34.51K
-131.40%-23.96K
-118.18%-13.51K
-117.22%-13.27K
--304.03K
--76.34K
-47.50%76.31K
--74.29K
Depreciation and amortization
593.40%22.81K
6.47%13.16K
0.00%3.29K
-0.09%3.29K
0.03%3.29K
32.23%3.29K
--12.36K
--3.29K
45.00%3.29K
--3.29K
Other non cash items
75.81%171.65K
119.47%484.76K
123.62%506.23K
-77.89%-46.99K
-549.63%-72.11K
1,902.28%97.63K
--220.88K
--226.38K
---26.42K
--16.04K
Change In working capital
-636.93%-2.84M
-293.55%-6.22M
-431.95%-6.54M
-63.27%1.01M
79.39%-1.22M
239.72%529.72K
---1.58M
--1.97M
21.99%2.75M
---5.92M
-Change in receivables
-172.15%-439.01K
-1,128.49%-839.73K
-187.66%-336.11K
-132.22%-100.99K
-1,083.98%-241.32K
62.73%-161.32K
---68.36K
--383.41K
22.39%-43.49K
--24.53K
-Change in prepaid assets
-175.44%-832.51K
-132.43%-6.35M
-2,507.34%-7.22M
2.62%650.1K
68.59%-884.52K
230.15%1.1M
---2.73M
--299.73K
37,766.59%633.51K
---2.82M
-Change in payables and accrued expense
-210.83%-1.16M
-8.41%1.26M
-9.51%1.3M
-78.64%461.67K
95.73%-133.76K
-141.45%-373.74K
--1.37M
--1.44M
-6.42%2.16M
---3.13M
-Change in other current assets
---5.44K
---65.51K
----
----
----
--0
--0
----
----
----
-Change in other current liabilities
-944.62%-405.58K
-45.82%-222.26K
----
----
----
---38.83K
---152.43K
----
----
----
Cash from discontinued investing activities
Operating cash flow
-65.64%-14.95M
23.47%-42.78M
-6.45%-12.34M
1.08%-9.25M
41.43%-12.16M
36.38%-9.02M
---55.89M
---11.6M
-363.27%-9.35M
---20.76M
Investing cash flow
Cash flow from continuing investing activities
-246.60%-28.8M
22.13%-25.18M
1,080.30%116.87M
-312.96%-174.38M
633,802,550.00%12.68M
122,826.62%19.65M
-32.34M
9.9M
-362,386.24%-42.23M
2
Net PPE purchase and sale
---211.77K
-1,677.96%-284.63K
-28,463,300.00%-284.63K
--0
--0
--0
---16.01K
---1
--0
--2
Net investment purchase and sale
-245.52%-28.59M
22.97%-24.9M
1,083.17%117.15M
-312.96%-174.38M
--12.68M
--19.65M
---32.32M
--9.9M
---42.23M
--0
Cash from discontinued investing activities
Investing cash flow
-246.60%-28.8M
22.13%-25.18M
1,080.30%116.87M
-312.96%-174.38M
633,802,550.00%12.68M
122,826.62%19.65M
---32.34M
--9.9M
-362,386.24%-42.23M
--2
Financing cash flow
Cash flow from continuing financing activities
50.98M
300.78%479.7M
749,475.71%28.42M
0
331.09%451.29M
0
119.69M
3.79K
0
104.69M
Net issuance payments of debt
----
--0
--0
--0
----
----
---15M
--0
--0
---30M
Net common stock issuance
--52.54M
--482.45M
--31.17M
--0
--451.29M
--0
--0
--0
--0
----
Proceeds from stock option exercised by employees
----
--0
----
----
----
----
--3.79K
----
----
----
Net other financing activities
---1.56M
-102.04%-2.75M
----
----
----
----
--134.69M
--0
--0
----
Cash from discontinued financing activities
Financing cash flow
--50.98M
300.78%479.7M
749,475.71%28.42M
--0
331.09%451.29M
--0
--119.69M
--3.79K
--0
--104.69M
Net cash flow
Beginning cash position
1,042.04%451.17M
391.43%39.51M
672.16%318.17M
441.26%501.79M
467.45%50.13M
391.43%39.51M
--8.04M
--41.2M
4,443.42%92.71M
--8.83M
Current changes in cash
-31.99%7.23M
1,208.84%411.74M
7,962.69%132.94M
-256.02%-183.63M
438.34%451.8M
1,225.00%10.62M
--31.46M
---1.69M
-3,266.85%-51.58M
--83.92M
Effect of exchange rate changes
8,786.92%46.48K
-981.81%-75.31K
881.32%64.74K
-93.26%5.01K
-183.38%-144.52K
91.77%-535
--8.54K
---8.29K
7,495.82%74.33K
---51K
End cash Position
814.52%458.44M
1,042.04%451.17M
1,042.04%451.17M
672.16%318.17M
441.26%501.79M
467.45%50.13M
--39.51M
--39.51M
8,018.17%41.2M
--92.71M
Free cash flow
-67.99%-15.16M
22.98%-43.06M
-8.91%-12.63M
1.08%-9.25M
41.43%-12.16M
36.46%-9.02M
---55.91M
---11.6M
-360.61%-9.35M
---20.76M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -65.64%-14.95M23.47%-42.78M-6.45%-12.34M1.08%-9.25M41.43%-12.16M36.38%-9.02M-55.89M-11.6M-363.27%-9.35M-20.76M
Net income from continuing operations -14.38%-13.98M31.67%-44.08M52.10%-7.89M21.18%-11.62M29.07%-12.35M23.05%-12.22M---64.51M---16.47M-134.44%-14.74M---17.42M
Operating gains losses 97.95%-272-128.04%-85.25K-145.21%-34.51K-131.40%-23.96K-118.18%-13.51K-117.22%-13.27K--304.03K--76.34K-47.50%76.31K--74.29K
Depreciation and amortization 593.40%22.81K6.47%13.16K0.00%3.29K-0.09%3.29K0.03%3.29K32.23%3.29K--12.36K--3.29K45.00%3.29K--3.29K
Other non cash items 75.81%171.65K119.47%484.76K123.62%506.23K-77.89%-46.99K-549.63%-72.11K1,902.28%97.63K--220.88K--226.38K---26.42K--16.04K
Change In working capital -636.93%-2.84M-293.55%-6.22M-431.95%-6.54M-63.27%1.01M79.39%-1.22M239.72%529.72K---1.58M--1.97M21.99%2.75M---5.92M
-Change in receivables -172.15%-439.01K-1,128.49%-839.73K-187.66%-336.11K-132.22%-100.99K-1,083.98%-241.32K62.73%-161.32K---68.36K--383.41K22.39%-43.49K--24.53K
-Change in prepaid assets -175.44%-832.51K-132.43%-6.35M-2,507.34%-7.22M2.62%650.1K68.59%-884.52K230.15%1.1M---2.73M--299.73K37,766.59%633.51K---2.82M
-Change in payables and accrued expense -210.83%-1.16M-8.41%1.26M-9.51%1.3M-78.64%461.67K95.73%-133.76K-141.45%-373.74K--1.37M--1.44M-6.42%2.16M---3.13M
-Change in other current assets ---5.44K---65.51K--------------0--0------------
-Change in other current liabilities -944.62%-405.58K-45.82%-222.26K---------------38.83K---152.43K------------
Cash from discontinued investing activities
Operating cash flow -65.64%-14.95M23.47%-42.78M-6.45%-12.34M1.08%-9.25M41.43%-12.16M36.38%-9.02M---55.89M---11.6M-363.27%-9.35M---20.76M
Investing cash flow
Cash flow from continuing investing activities -246.60%-28.8M22.13%-25.18M1,080.30%116.87M-312.96%-174.38M633,802,550.00%12.68M122,826.62%19.65M-32.34M9.9M-362,386.24%-42.23M2
Net PPE purchase and sale ---211.77K-1,677.96%-284.63K-28,463,300.00%-284.63K--0--0--0---16.01K---1--0--2
Net investment purchase and sale -245.52%-28.59M22.97%-24.9M1,083.17%117.15M-312.96%-174.38M--12.68M--19.65M---32.32M--9.9M---42.23M--0
Cash from discontinued investing activities
Investing cash flow -246.60%-28.8M22.13%-25.18M1,080.30%116.87M-312.96%-174.38M633,802,550.00%12.68M122,826.62%19.65M---32.34M--9.9M-362,386.24%-42.23M--2
Financing cash flow
Cash flow from continuing financing activities 50.98M300.78%479.7M749,475.71%28.42M0331.09%451.29M0119.69M3.79K0104.69M
Net issuance payments of debt ------0--0--0-----------15M--0--0---30M
Net common stock issuance --52.54M--482.45M--31.17M--0--451.29M--0--0--0--0----
Proceeds from stock option exercised by employees ------0------------------3.79K------------
Net other financing activities ---1.56M-102.04%-2.75M------------------134.69M--0--0----
Cash from discontinued financing activities
Financing cash flow --50.98M300.78%479.7M749,475.71%28.42M--0331.09%451.29M--0--119.69M--3.79K--0--104.69M
Net cash flow
Beginning cash position 1,042.04%451.17M391.43%39.51M672.16%318.17M441.26%501.79M467.45%50.13M391.43%39.51M--8.04M--41.2M4,443.42%92.71M--8.83M
Current changes in cash -31.99%7.23M1,208.84%411.74M7,962.69%132.94M-256.02%-183.63M438.34%451.8M1,225.00%10.62M--31.46M---1.69M-3,266.85%-51.58M--83.92M
Effect of exchange rate changes 8,786.92%46.48K-981.81%-75.31K881.32%64.74K-93.26%5.01K-183.38%-144.52K91.77%-535--8.54K---8.29K7,495.82%74.33K---51K
End cash Position 814.52%458.44M1,042.04%451.17M1,042.04%451.17M672.16%318.17M441.26%501.79M467.45%50.13M--39.51M--39.51M8,018.17%41.2M--92.71M
Free cash flow -67.99%-15.16M22.98%-43.06M-8.91%-12.63M1.08%-9.25M41.43%-12.16M36.46%-9.02M---55.91M---11.6M-360.61%-9.35M---20.76M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg